Abstract
In this brief review a list of potential pathogens is provided that are associated with Kaposi’s sarcoma (KS) and may contribute to the initiation and/or maintenance of growth of KS cells. For the end result, which is the characteristic appearance and grouping of KS cells, the same growth factors are needed in a set sequence and combination. However, the pathogens inducing these growth factors may be different. Induction of the same growth factors by diverse pathogens can result in the generation of endothelial cell growth and transformation in sequence recognized as various subtypes of KS. Indeed there has to be an initiator of growth factor release from CD4 lymphocytes other than HIV in classical (Mediterranean) KS. On the other hand, HIV infection alone is not enough to induce KS: patients with hemophilia acquiring HIV infection through blood products die with AIDS but without developing KS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. McKeating, P.D. Griffiths, RA. Weiss, HIV susceptibility conferred to human fibroblasts bycytomegalovirus-induced Fc receptor, Nature 343:659 (1990).
J. D. Benson, E.S. Huang, Human cytomegalovirus induces expression of cellular topoisomerase II, JVirol. 64:9 (1990).
B. J. Thomas, S. Efstathion, R.W. Honess, Acquisition of the human adeno-associated virus type-2 repgene by human herpesvirus type-6, Nature 351:78 (1991).
R. I. Short, D. Jones, R. Kost, R. Witter, H-J Kung, Retrovirus insertion into herpesvirus in vitro andin vivo, Proc. Nat. Acad. Sci. USA 89:991 (1992).
D. H. Spector, J.P. Vacquier, Human cytomegalovirus (strain AD 169) contains sequences related to theavian retrovirus oncogene v-mvc,Proc. Nat. Acad. Sci. USA 80:3889 (1983).
I. Boldogh, E. Beth, E-S Huang, S.K. Kyalwazi, G. Giraldo, Kaposi sarcoma. IV. Detection of CMVDNA, CMV RNA and CMNA in tumor biopsies, Internat J. Cancer 28:469 (1981).
G. Giraldo, E. Beth, E-S Huang, Kaposi’s sarcoma and its relationship to cytomegalovirus (CMV) III.CMV DNA and CMV early antigen in Kaposi’s sarcoma, Internat J. Cancer 26:23 (1980).
D. H. Spector, S.B. Shaw, C.J. Hock, D. Alvans, T. Mitsuyasu, M. Gottlieb, Association of humancytomegalovirus with Kaposi’s sarcoma, in: “Acquired Immune Deficiency Syndrome,” .S. Gottlieb, J.C. Groopman, eds., Proc Schering Corp UCLA Symposium, Allen R. Liss, New York, pp 109 (1984).
H. L. Ioachim, B. Dorsett, J. Melamed, V. Adsay, E.A. Santagada, Cytomegalovirus, angiomatosis and Kaposi’s sarcoma: new observations of a debated relationship, Modern Pathol. 5:169 (1992).
F. Gyorkey, J.G. Sinkovics, R.J. Luchi, J.D. Small, P. Craig, R. Rossen, P. Gyorkey, J. Melnick, Kaposi’ssarcoma in lymph nodes of patients with cytomegalovirus viremia, Proc. Am. Assoc. Cancer Res. 23:280 (Abstr. 1106) (1982).
R. F. Ambinder, C. Newman, G.S. Hayward, R. Bigger, M. Melbye, L. Kesters, E.V. March, P. Piot,P. Gigase, P.B. Wright, T.C. Quinn, Lack of association of cytomegalovirus with endemic African Kaposi’s sarcoma, J. Infect. Dis. 156:193 (1987).
A. Siddiqui, Hepatitis B virus DNA in Kaposi sarcoma, Proc. Natl. Acad. Sci. USA 80:4861 (1983).
Y. O. Huang, J.J. Li, M.G. Rush, B.J. Poiesz, A. Nicolaides, M. Jacobson, W.G. Zhang, E. Coutavas MA. Abbott, A.E. Friedman-Kien, HPV-16-related DNA sequences in Kaposi’s sarcoma, Lancet 339:515 (1992).
G. Barbanti-Brodano, M. Pagnani, P.G. Balboni, Studies on the association of Kaposi’s sarcoma with ubiquitous viruses, in: “AIDS and Associated Cancers in Africa, G. Giraldo, E. Beth-Giraldo, N. Clumeck, M-R Gharbi, S.K. Kyalwazi, G. de The, eds., Karger, Basel, pp 175 (1988).
F. Gyorkey, J.G. Sinkovics, J.L. Melnick, P. Gyorkey, Retroviruses in Kaposi sarcoma cells in AIDS, New Engt J. Med. 311:1183 (1984).
K. Rappensberger, E. Tschachler, E. Zonzits, R. Gillitzer, A. Hatzakes, A. Kaloterakis, D.L. Mann, T.Popow-Kraupp, R J. Bigger, R. Berger, J. Stratigos, K. Wolff, G. Stingl, Endemic Kaposi’s sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions, J. Invest. Dermatol. 95:371 (1990).
D. A. Spandidos, A. Kaloterakis, M. Yiagnisis, A. Varatsas, J.K. Field, Ras, c-myc and c-erbB2oncoprotein expression in non-AIDS Mediterranean Kaposi’s sarcoma, Anticancer Res. 10:1619 (1990).
F. Gyorkey, J.G. Sinkovics, K.W. Min, P. Gyorkey, A morphologic study on the occurrence and distribution of structures resembling viral nucleocapsids in collagen diseases, Am. J. Med 53:148 (1972).
J. G. Sinkovics, Tubuloreticular structures (TRS) in hairy cell leukemia, J. Biol. Resp. Modif. 6:573(1987).
F. Gyorkey, J.G. Sinkovics, P. Gyorkey, Tubuloreticular structures in Kaposi’s sarcoma, Lancet 2:984(1982).
S. A. Rich, T.R. Owens, L.E. Bartholomew, J.U. Gutterman, Immune interferon does not stimulateformation of alpha and beta interferon-induced human lupus type inclusions, Lancet 1:127 (1983).
J. Vogel, S.H. Hinrich, R.K. Reynolds, PA. Luciw, G. Jay, The HIV tat gene induces dermal lesions resembling Kaposi’s sarcoma in transgenic mice, Nature 335:606 (1985).
B. R. Cullen, The HIV-1 Tat protein: an RNA sequence-specific processivity factor, Cell 63:655 (1990).
B. Ensoli, G. Barillari, S.Z. Salahuddin, R.C. Gallo, F. Wong-Staal, Tat protein of HIV-1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients, Nature 345:84 (1990).
D. A. Relman, J.S. Loutit, T.M. Schmidt, S. Falkow, L.S. Tompkins, The agent of bacillary angiomatosis, New Engl. J. Med. 323:1573 (1990).
T. A. Steeper, H. Rosenstein ,J. Weiser, S. Inanipudi ,D.C. Snover ,Bacillary epithelioid angiomatosis involving the liver, spleen and skin in an AIDS patient with concurrent Kaposi’s sarcoma, Am. J. Clin. Pathol. 97:713 (1992).
T. S. Croxson, D. Ebanks, D. Mildvan, Atypical mycobacteria and Kaposi’s sarcoma in the same biopsy specimens, New Engl. J. Med. 308:1476 (1983).
D. K. Blanchard, M.B. Michelin-Norris, CA. Pearson, C.S. Freitag, J.Y. Djeu, Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes, Blood 77:2218 (1991).
S-C Lo, S. Tsai, J.R. Benish, J.W. Shih, D.J. Wear, D.M. Wong, Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma, Science 251:1074 (1991).
S-C Lo, C.L. Buckholz, DJ. Wear, R.C. Hohm, A.M. Marty, Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitusstrain), Modem Pathol. 4:750 (1991)
B. Ensoli, G. Barillari, R.C. Gallo, Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi’s sarcoma, Immunol. Reviews 127:147 (1992).
B. C. Nair, A.L. DeVico, S. Nakamura, T.D. Copeland, Y. Chen, A. Patel, T. O’Neil, S. Oroszlan, R.C. Gallo, M.G. Sarngadharan, Identification of a major growth factor for AIDS-Kaposi’s sarcoma cells is oncostatin M, Science 255:1430 (1992).
J. Corbeil, LA. Evans, E. Vasak, D.A. Cooper, R. Penny, Culture and properties of cells derived from Kaposi sarcoma, J. Immunol. 146:2972 (1991).
S. A. Miles, A.R. Rezai, J.F. Sabazar-Gonzalez, M. Vander Meyden, R.H. Stevens, D.M. Logan, R.T. Mitsuyasu, T. Taga, T. Hirano, T. Kishimoto, O. Martinez-Maza, AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6, Proc. Natl. Acad. Sci. USA 87:4068 (1990).
P. Delli Bovi, A.M. Curatola, F.G. Kern, A. Greco, M. Ittmann, C. Basilico, An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family, Cell 50:729 (1987).
L. Xerri, J. Hassoun, J. Planche, V. Guigou, J-J Grob, P. Pare, D. Birnbaum, O. de Lapeyriere, Fibroblast growth factor gene expression in AIDS-Kaposi’s sarcoma detected by in situ hybridization, Am. J. Pathol. 138:9 (1991).
O. Brüstle, A. Aguzzi, D. Talarico, C. Basilico, P. Kleihues, O. Wiestler, Angiogenic activity of the K- fgf-hst oncogene in neural transplants, Oncogene 7:1177 (1992).
H. A. Weich, S.Z. Salahuddin, P. Gill, S. Nakamura, R.C. Gallo, J. Folkmann, AIDS-associated Kaposi’s sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin, Am. J. Pathol. 139:1251 (1991).
S. A. Miles, O. Martinez-Maza, A. Rezai, L. Magpantay, T. Kishimoto, S. Nakamura, S.F. Radka, P.S. Linsey, Oncostatin M as a potent mitogen for AIDS-Kaposi’s sarcoma-derived cells, Science 255:1432 (1992).
D. P. Gearing, M.R. Comeau, DJ. Friend, S.D. Gimpel, C.J. Thut, J. McGourty, K.K. Brasher, JA. King, S. Gillis, B. Mosley, S.F. Ziegler, D. Cosman, The IL-6 signal transducer gp130: an oncostatin M receptor and affinity converter for the L1F receptor, Science 255:1434 (1992).
L. F. Fajardo, H.H. Kwan, J. Kowalski, S.D. Prionas, A.C. Allison, Dual role of tumor necrosis factor-a in angiogenesis, Am. J. Pathol. 140:539 (1992).
G. Poli, A.L. Kinter, J.S. Justement, P. Bressler, J.H. Kehrl, A.S. Fauci, Retinoic acid mimics transforming growth factor ß in the regulation of human immunodeficiency virus expression in monocytic cells, Proc. Nat. Acad. Sci. USA 89:2689 (1992).
J. A. Turpin, M. Vargo, M.S. Meltzer, Enhanced HIV-1 replication in retinoid-treated monocytes, J. Immune 148:2539 (1992).
J. Folkmann, How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res. 46:461 (1986).
A. Wellstein, G. Zugmaier, JA. Califaro, F. Kern, S. Paih, M.E. Lippman, Tumor growth dependent on Kaposi’s sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate, J. Nat. Cancer Inst. 83:716 (1991).
Editorial. Exploiting angiogenesis, Lancet 337:208 (1991).
T. E. Maione, G.S. Gray, J. Petro, A.J. Hunt, A.L. Donner, S.I. Bauer, H.F. Carson, R.J. Sharpe, Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides, Science 247:77 (1990).
S. Kumar, Control of tumor growth: endothelial cell as an alternative target, Anticancer Res. 10:1443 (1990).
S.S. Brenn, D. Zagzag, A.M.C. Tsanaclis, S. Gately, M-P Elkouby, S.E. Brien, Inhibition of angiogenesis and tumor growth in the brain, J. Pathol. 137:1121 (1990).
B. Robaye, R. Mosselmans, W. Fiers, J.E. Dumont, P. Galand, Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro, J. Pathol. 138:447 (1991).
J. E. Szakacs quoted in J.G. Sinkovics, Kaposi’s sarcoma: its oncogenes and growth factors, Crit. Rev. Hem-One. 11:87 (1991).
J. G. Sinkovics, Interferons: antiangiogenesis agents, Can. J. Inf. Dis. 3:Suppl. X 1 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sinkovics, J.G., Szakacs, J.E., Gyorkey, F. (1993). Multiple Pathogens May Induce Growth Factor Cascade Resulting in KS. In: Friedman, H., Klein, T.W., Specter, S. (eds) Drugs of Abuse, Immunity, and AIDS. Advances in Experimental Medicine and Biology, vol 335. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2980-4_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2980-4_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6297-5
Online ISBN: 978-1-4615-2980-4
eBook Packages: Springer Book Archive